Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2021-10-07 20:38:43 UTC |
---|
NP-MRD ID | NP0000903 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Deoxyinosine |
---|
Description | Deoxyinosine is a nucleoside that is formed when hypoxanthine is attached to a deoxyribose ring (also known as a ribofuranose) via a beta-N9-glycosidic bond. Deoxyinosine is found in DNA while inosine is found in RNA. Inosine is a nucleic acid important for RNA editing. Adenosine deaminase (ADA) catalyzes the conversion of adenosine and deoxyadenosine to inosine and deoxyinosine, respectively. ADA-deficient individuals suffer from severe combined immunodeficiency (SCID) and are unable to produce significant numbers of mature T or B lymphocytes. This occurs as a consequence of the accumulation of ADA substrates or their metabolites. Inosine is also an intermediate in a chain of purine nucleotides reactions required for muscle movements. Moreover, deoxyinosine is found to be associated with purine nucleoside phosphorylase (PNP) deficiency, which is an inborn error of metabolism. |
---|
Structure | OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1 |
---|
Synonyms | Value | Source |
---|
9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-9H-purin-6-ol | ChEBI | 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-9H-purin-6-ol | Generator | 9-(2-Deoxy-β-D-erythro-pentofuranosyl)-9H-purin-6-ol | Generator | 2'-Deoxyinosine | HMDB | 2-Deoxy-inosine | HMDB | 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one | HMDB | 9-(2-Deoxy-b-D-erythro-pentofuranosyl)-hypoxanthine | HMDB | 9-(2-Deoxy-beta-D-erythro-pentofuranosyl)-hypoxanthine | HMDB | 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-1,9-dihydro-6H-purin-6-one | HMDB | 9-(2-Deoxy-beta-delta-erythro-pentofuranosyl)-hypoxanthine | HMDB | D-Ino | HMDB | delta-Ino | HMDB | DInosine | HMDB | Deoxyribose-inosine | HMDB | Deoxyinosine | ChEBI |
|
---|
Chemical Formula | C10H12N4O4 |
---|
Average Mass | 252.2300 Da |
---|
Monoisotopic Mass | 252.08585 Da |
---|
IUPAC Name | 9-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-6-ol |
---|
Traditional Name | 2'-deoxy-inosine |
---|
CAS Registry Number | 890-38-0 |
---|
SMILES | OC[C@H]1O[C@H](C[C@@H]1O)N1C=NC2=C1N=CNC2=O |
---|
InChI Identifier | InChI=1S/C10H12N4O4/c15-2-6-5(16)1-7(18-6)14-4-13-8-9(14)11-3-12-10(8)17/h3-7,15-16H,1-2H2,(H,11,12,17)/t5-,6+,7+/m0/s1 |
---|
InChI Key | VGONTNSXDCQUGY-RRKCRQDMSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as purine 2'-deoxyribonucleosides. Purine 2'-deoxyribonucleosides are compounds consisting of a purine linked to a ribose which lacks a hydroxyl group at position 2. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Purine nucleosides |
---|
Sub Class | Purine 2'-deoxyribonucleosides |
---|
Direct Parent | Purine 2'-deoxyribonucleosides |
---|
Alternative Parents | |
---|
Substituents | - Purine 2'-deoxyribonucleoside
- Hypoxanthine
- Imidazopyrimidine
- Purine
- Hydroxypyrimidine
- N-substituted imidazole
- Pyrimidine
- Tetrahydrofuran
- Heteroaromatic compound
- Azole
- Imidazole
- Secondary alcohol
- Azacycle
- Organoheterocyclic compound
- Oxacycle
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Alcohol
- Organic oxygen compound
- Primary alcohol
- Organic nitrogen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | 250 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 32500 mg/L @ 25 °C (est) | The Good Scents Company Information System | LogP | -1.71 | Barchi Jr, J. J., Marquez, V. E., Driscoll, J. S., Ford Jr, H., Mitsuya, H., Shirasaka, T., Aoki, S., & Kelley, J. A. (1991). Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. Journal of medicinal chemistry, 34(5), 1647-1655. |
|
---|
Predicted Properties | |
---|
General References | - Cohen A, Doyle D, Martin DW Jr, Ammann AJ: Abnormal purine metabolism and purine overproduction in a patient deficient in purine nucleoside phosphorylase. N Engl J Med. 1976 Dec 23;295(26):1449-54. [PubMed:825775 ]
- Kewn S, Hoggard PG, Henry-Mowatt JS, Veal GJ, Sales SD, Barry MG, Back DJ: Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro. AIDS Res Hum Retroviruses. 1999 Jun 10;15(9):793-802. [PubMed:10381167 ]
- Bemi V, Tazzni N, Banditelli S, Giorgelli F, Pesi R, Turchi G, Mattana A, Sgarrella F, Tozzi MG, Camici M: Deoxyadenosine metabolism in a human colon-carcinoma cell line (LoVo) in relation to its cytotoxic effect in combination with deoxycoformycin. Int J Cancer. 1998 Mar 2;75(5):713-20. [PubMed:9495239 ]
- Chantin C, Bonin B, Boulieu R, Bory C: Liquid-chromatographic study of purine metabolism abnormalities in purine nucleoside phosphorylase deficiency. Clin Chem. 1996 Feb;42(2):326-8. [PubMed:8595732 ]
- Ablett E, Pedley J, Dannoy PA, Sturm RA, Parsons PG: UVB-specific regulation of gene expression in human melanocytic cells: cell cycle effects and implication in the generation of melanoma. Mutat Res. 1998 Nov 9;422(1):31-41. [PubMed:9920426 ]
- Bazar LS, Collier GB, Vanek PG, Siles BA, Kow YW, Doetsch PW, Cunningham RP, Chirikjian JG: Mutation identification DNA analysis system (MIDAS) for detection of known mutations. Electrophoresis. 1999 Jun;20(6):1141-8. [PubMed:10380753 ]
- Sjoberg AH, Wang L, Eriksson S: Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. Mol Pharmacol. 1998 Feb;53(2):270-3. [PubMed:9463485 ]
|
---|